Author: Ershad Moradi

CRF vs eCRF in Clinical Trials

CRF vs eCRF in 2026: Essential Differences in Clinical Trials

CRF vs eCRF choices shape clinical trial data quality, speed, traceability, and compliance. This guide explains paper workflows, electronic data capture, audit trails, validation, query management, CDISC alignment, and practical selection factors. Read it to understand modern clinical data collection clearly and confidently.

Read More »
Clinical data management professionals review anonymized trial dashboards and data trends.

Clinical Data Management in 2026: Process, Systems and Career Guide

Clinical data management turns scattered trial observations into reliable, traceable datasets. This guide explains eCRF design, edit checks, external data reconciliation, database lock, and clinical data manager responsibilities. Explore essential controls, compare team handoffs, and build the skills needed for informed study decisions.

Read More »
CAPA and Deviation Review in Pharma

CAPA vs Deviation in Pharma: Differences and Examples in 2026

CAPA vs deviation becomes clearer when teams separate event investigation from systemic action. This guide explains GMP departures, product impact, root cause, escalation criteria, and effectiveness checks. Compare practical examples, follow the workflow, and strengthen your next quality decision with evidence and risk.

Read More »
FMEA in Pharma

FMEA in Pharma in 2026: A Practical Guide to Risk Assessment and Control

This practical guide explains FMEA in pharma, from defining scope through residual-risk review. Learn severity, occurrence, detection, RPN calculation, pharmaceutical applications, and control planning. Follow a worked tablet-compression example, compare related tools, and build clearer, science-based quality risk assessments with confidence during operations.

Read More »
5 Whys Root Cause Analysis in Pharma: Key Steps and Guide in 2026

5 Whys Root Cause Analysis in Pharma: Key Steps and Guide in 2026

Learn how pharmaceutical teams apply 5 Whys root cause analysis to deviations, OOS results, complaints, and CAPA investigations. Follow a verified workflow, review a tablet weight example, compare leading RCA tools, avoid common mistakes, and strengthen lasting quality improvements across operations confidently today.

Read More »
Secure Drug Master File Management

Drug Master File in 2026 Main Types and Key Requirements

A drug master file protects confidential manufacturing knowledge while supporting FDA application reviews. This guide explains DMF types, authorization, eCTD structure, review pathways, amendments, annual reports, and practical controls. Use it to prepare stronger submissions and maintain regulatory references throughout the product lifecycle.

Read More »
Global Regulatory Intelligence in Pharma

Regulatory Intelligence in Pharma: A Practical Guide for 2026

Regulatory intelligence helps pharma teams monitor changing requirements, assess business impact, and act before risks grow. This practical guide explains trusted sources, structured workflows, technology, AI support, impact assessment, change management, and global alignment. Use it to build faster, clearer regulatory decisions today.

Read More »
Regulatory team reviewing an IND application package before clinical trials.

IND Application in 2026: A Complete FDA Submission Guide

Learn how an IND application moves from preclinical evidence to FDA review. This guide explains forms, CMC, toxicology, clinical protocols, exemptions, eCTD submission, expanded access, clinical holds, and the 30-day process. Use it to prepare clearer, review-ready submissions for development teams in 2026.

Read More »